Cardiovascular Systems ROE 2006-2019 | CSII

Current and historical return on equity (ROE) values for Cardiovascular Systems (CSII) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Cardiovascular Systems ROE for the three months ending September 30, 2019 was -2.21%.
Cardiovascular Systems ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-09-30 $-0.00B $0.14B -2.80%
2019-06-30 $-0.00B $0.15B -0.71%
2019-03-31 $0.00B $0.14B 1.46%
2018-12-31 $0.00B $0.14B 0.75%
2018-09-30 $0.00B $0.13B 0.77%
2018-06-30 $0.00B $0.13B 1.59%
2018-03-31 $-0.00B $0.13B -0.82%
2017-12-31 $-0.00B $0.12B -2.53%
2017-09-30 $-0.00B $0.12B -1.73%
2017-06-30 $-0.00B $0.12B -1.79%
2017-03-31 $-0.01B $0.11B -7.46%
2016-12-31 $-0.03B $0.11B -27.75%
2016-09-30 $-0.05B $0.10B -42.15%
2016-06-30 $-0.06B $0.10B -49.23%
2016-03-31 $-0.06B $0.10B -48.68%
2015-12-31 $-0.05B $0.12B -35.96%
2015-09-30 $-0.04B $0.13B -27.09%
2015-06-30 $-0.03B $0.14B -22.84%
2015-03-31 $-0.03B $0.14B -23.01%
2014-12-31 $-0.03B $0.15B -21.85%
2014-09-30 $-0.04B $0.15B -24.18%
2014-06-30 $-0.04B $0.15B -27.22%
2014-03-31 $-0.03B $0.16B -29.73%
2013-12-31 $-0.03B $0.16B -32.40%
2013-09-30 $-0.03B $0.07B -45.02%
2013-06-30 $-0.02B $0.07B -49.23%
2013-03-31 $-0.02B $0.07B -55.00%
2012-12-31 $-0.02B $0.03B -73.39%
2012-09-30 $-0.02B $0.03B -70.59%
2012-06-30 $-0.02B $0.03B -70.83%
2012-03-31 $-0.01B $0.02B -65.12%
2011-12-31 $-0.01B $0.02B -57.14%
2011-09-30 $-0.01B $0.02B -50.63%
2011-06-30 $-0.01B $0.02B -56.34%
2011-03-31 $-0.01B $0.02B -71.64%
2010-12-31 $-0.02B $0.02B -100.00%
2010-09-30 $-0.02B $0.02B -118.92%
2010-06-30 $-0.02B $0.02B -111.63%
2010-03-31 $-0.03B $0.02B -106.12%
2009-12-31 $0.00B $0.02B 10.53%
2009-06-30 $0.00B $0.03B 7.34%
2009-03-31 $-0.01B $0.03B -55.70%
2008-06-30 $-0.06B -130.23%
2008-03-31 $0.01B $0.07B 11.35%
2007-06-30 $0.03B $0.11B 47.43%
2007-03-31 $-0.02B $0.06B -52.17%
2006-09-30 $-0.04B $0.08B -86.86%
2006-06-30 $-0.04B $0.04B -176.84%
2006-03-31 $-0.04B -303.70%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.522B $0.248B
Cardiovascular Systems, Inc., formerly known as Replidyne Inc., is headquartered in Saint Paul, Minnesota. It is a medical device company focusing on developing and commercializing interventional treatment systems for vascular disease. Its initial product, the Diamondback 360? Orbital Atherectomy System, is a minimally invasive catheter system for the treatment of peripheral arterial disease; and a range of plaque types, including calcified vessel lesions. The Diamondback 360? removes soft and calcified plaque in plaque-lined vessels through the orbital rotation of a diamond grit coated offset crown. The company refined its `orbital` technology to address the growing market need of providing a safer more effective atherectomy device.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $149.261B 20.95
Abbott Laboratories (ABT) United States $149.010B 27.18
Stryker (SYK) United States $76.714B 25.79
Boston Scientific (BSX) United States $58.945B 27.82
Baxter (BAX) United States $41.416B 25.11
EssilorLuxottica Societe Anonyme (ESLOY) France $33.904B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.822B 18.71
Terumo (TRUMY) Japan $26.925B 33.60
Coloplast (CLPBY) Denmark $25.499B 40.71
Lonza Group Ag (LZAGY) Switzerland $25.289B 0.00
ResMed (RMD) United States $21.249B 39.20
Smith & Nephew SNATS (SNN) United Kingdom $19.012B 0.00
Sunny Optical Technology (SNPTF) China $17.210B 0.00
Insulet (PODD) United States $11.282B 536.73
Bio-Rad Laboratories (BIO) United States $10.725B 51.48
Hill-Rom Holdings (HRC) United States $6.983B 20.59
Perrigo (PRGO) Ireland $6.665B 12.43
William Demant Holdings (WILYY) Denmark $6.665B 0.00
DiaSorin S.p.A (DSRLF) Italy $6.420B 0.00
Haemonetics (HAE) United States $6.037B 40.79
Shandong Weigao Medical Polymer (SHWGF) China $5.382B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
Canopy Growth (CGC) Canada $4.955B 0.00
NuVasive (NUVA) United States $3.778B 29.75
ICU Medical (ICUI) United States $3.688B 24.04
Neogen (NEOG) United States $3.350B 56.05
GW Pharmaceuticals (GWPH) United Kingdom $3.165B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.147B 0.00
Quidel (QDEL) United States $2.687B 25.50
Aurora Cannabis (ACB) Canada $2.346B 0.00
National Vision Holdings (EYE) United States $2.162B 48.80
Agios Pharmaceuticals (AGIO) United States $2.128B 0.00
InMode (INMD) Israel $1.670B 0.00
AtriCure (ATRC) United States $1.126B 0.00
VAREX IMAGING (VREX) United States $1.125B 22.54
Aphria (APHA) $0.961B 0.00
Phibro Animal Health (PAHC) United States $0.923B 17.28
NanoString Technologies (NSTG) United States $0.838B 0.00
Lantheus Holdings (LNTH) United States $0.825B 20.62
TG Therapeutics (TGTX) United States $0.790B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.777B 29.75
LeMaitre Vascular (LMAT) United States $0.685B 38.49
Omeros (OMER) United States $0.661B 0.00
PetIQ (PETQ) United States $0.655B 15.99
Quanterix (QTRX) United States $0.628B 0.00
Cerus (CERS) United States $0.613B 0.00
Surmodics (SRDX) United States $0.533B 55.68
OraSure Technologies (OSUR) United States $0.484B 29.04
Owens & Minor (OMI) United States $0.419B 15.51
MacroGenics (MGNX) United States $0.413B 0.00
HEXO (HEXO) $0.409B 0.00
Utah Medical Products (UTMD) United States $0.378B 27.36
Meridian Bioscience (VIVO) United States $0.374B 12.88
Organigram Holdings (OGI) Canada $0.322B 0.00
BioLife Solutions (BLFS) United States $0.302B 123.08
Zynex (ZYXI) United States $0.299B 33.81
Vapotherm (VAPO) United States $0.244B 0.00
United Health Products (UEEC) United States $0.240B 0.00
Viemed Healthcare (VMD) United States $0.239B 0.00
Bovie Medical (APYX) United States $0.239B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.233B 0.00
Repro-Med Systems (KRMD) United States $0.164B 0.00
InfuSystems Holdings (INFU) United States $0.146B 734.00
Cytosorbents (CTSO) United States $0.133B 0.00
Rockwell Medical (RMTI) United States $0.131B 0.00
Fonar (FONR) United States $0.130B 9.18
Liberty Health Sciences (LHSIF) Canada $0.124B 0.00
Female Health (VERU) United States $0.123B 0.00
Chimerix (CMRX) United States $0.122B 0.00
United-Guardian (UG) United States $0.088B 22.24
Chembio Diagnostics (CEMI) United States $0.079B 0.00
Nephros (NEPH) United States $0.064B 0.00
MTech Acquisition (KERN) United States $0.057B 0.00
MRI Interventions (MRIC) United States $0.056B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.046B 0.00
Surface Oncology (SURF) United States $0.045B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.018B 0.00
GUARDION HEALTH (GHSI) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Myomo (MYO) United States $0.009B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Akers Biosciences Inc (AKER) United States $0.003B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00